TREATMENT OF SKIN DISEASES AND DISORDERS USING INHIBITORS OF KALLIKREIN-RELATED PEPTIDASES (KLK)

TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS

METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

Methods and materials for modulating resistance to apoptosis using KLK6 antisense and MIRNA molecules

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

Methods for increasing susceptibility to apoptosis by administering an inhibitor of kallikrein 6 polypeptide activity

Methods for modulating resistance to apoptosis using KLK6

TISSUE KALLIKREIN FOR THE TREATMENT OF PARKINSON'S DISEASE